Citation and link to original article
- Wells J, Wang C, Dolgin K, Kayyali R. SPUR: A Patient-Reported Medication Adherence Model as a Predictor of Admission and Early Readmission in Patients Living with Type 2 Diabetes. Patient Prefer Adherence. 2023 Feb 19;17:441-455.
- https://doi.org/10.2147/ppa.s397424
Purpose: Poor medication adherence (MA) is linked to an increased likelihood of hospital admission. Early interventions to address MA may reduce this risk and associated health-care costs. This study aimed to evaluate a holistic Patient Reported Outcome Measure (PROM) of MA, known as SPUR, as a predictor of general admission and early readmission in patients living with Type 2 Diabetes.
Patients and Methods: An observational study design was used to assess data collected over a 12-month period including 6-month retrospective and 6-month prospective monitoring of the number of admissions and early readmissions (admissions occurring within 30 days of discharge) across the cohort. Patients (n = 200) were recruited from a large South London NHS Trust. Covariates of interest included: age, ethnicity, gender, level of education, income, the number of medicines and medical conditions, and a Covid-19 diagnosis. A Poisson or negative binomial model was employed for count outcomes, with the exponentiated coefficient indicating incident ratios (IR) [95% CI]. For binary outcomes (Coefficient, [95% CI]), a logistic regression model was developed.
Results: Higher SPUR scores (increased adherence) were significantly associated with a lower number of admissions (IR = 0.98,[0.96, 1.00]). The number of medical conditions (IR = 1.07, [1.01, 1.13]), age ≥80 years (IR = 5.18, [1.01, 26.55]), a positive Covid-19 diagnosis during follow-up (IR = 1.83, [1.11, 3.02]) and GCSE education (IR = 2.11, [1.15,3.87]) were factors associated with a greater risk of admission. When modelled as a binary variable, only the SPUR score (−0.051, [−0.094, −0.007]) was significantly predictive of an early readmission, with patients reporting higher SPUR scores being less likely to experience an early readmission.
Conclusion: Higher levels of MA, as determined by SPUR, were significantly associated with a lower risk of general admissions and
early readmissions among patients living with Type 2 Diabetes.
Télécharger le poster SPUR et prédiction de l'hospitalisation dans le DT2 (en Anglais)
Nous traitons ces données uniquement à votre demande. Nous hébergeons les données en interne. Nous ne les partagerons pas. Ces informations seront utilisées pour vous envoyer des informations de la part de l'équipe de l'auteur, et vous ne serez abonné à aucune newsletter ou autre communication de marketing. Nous conservons les données pour une durée maximale de 3 ans sur des serveurs sécurisés. Vous pouvez nous envoyer une demande d'accès à vos données, demander leur suppression ou correction, ou restreindre notre traitement de vos données. Vous avez le droit de déposer une plainte concernant la façon dont nous traitons vos données auprès de l'autorité française de protection des données CNIL, ou vous pouvez contacter notre délégué à la protection des données à l'adresse Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser. pour plus d'informations ou en cas de problème. Veuillez consulter notre politique de confidentialité..